ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685833 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685833; 2) Community: the network communities that were significantly associated with the response to NSC 685833; 3) Molecule: the relationships between components within communities and NSC 685833; 4) MDR: the compounds that were significantly associated with the NSC 685833.

NSC Compound Enrichment Correlation
NSC 743396 Null 0.012374497233828 0.46180566
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.012374497233828 0.20793089
NSC 745343 1-Benzyl-3-hexadecyl-2-methylimidazolium chloride 0.012374497233828 0.20284557
NSC 747447 3,19-(4-N,N-dimethylamino)benzylidineandrographolide 0.012374497233828 0.55379961
NSC 748404 Null 0.012374497233828 0.39856903
NSC 752365 2-[6-(4-Hydroxy-3-methoxy-benzylamino)-hexyl]-benzo[de]isoquinoline-1,3-dione para toluen sulphonate 0.012374497233828 0.28952135
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.012374497233828 0.41547861
NSC 112758 Rubomycin 0.0123744972338281 0.19534248
NSC 129518 Cyclopyrethrosin 0.0123744972338281 0.5519009
NSC 1390 Allopurinol 0.0123744972338281 0.34735877
Total:144  Current:56    [First] [Prev] [Next] [Last]